Tempest Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $486 |
Gross Profit | -65 | -66 | -67 | -68 |
EBITDA | -3,956 | -3,445 | -7,757 | -10,631 |
EBIT | -4,021 | -3,511 | -7,824 | -10,699 |
Net Income | -4,021 | -3,511 | -7,870 | -10,860 |
Net Change In Cash | 0 | 0 | 0 | 486 |
Free Cash Flow | -24,503 | -6,779 | -8,431 | -8,036 |
Cash | 7,707 | 7,514 | 14,280 | 21,511 |
Basic Shares | 4,149 | 4,440 | 3,802 | 3,437 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -389 | -381 | -1,814 | |
EBITDA | -25,789 | -40,138 | -27,661 | -33,453 |
EBIT | -26,055 | -40,527 | -28,042 | -34,091 |
Net Income | -26,262 | -41,843 | -29,491 | -35,709 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -26,820 | -33,462 | -27,527 | -31,634 |
Cash | 7,707 | 30,268 | 39,230 | 31,230 |
Basic Shares | 4,149 | 27,902 | 15,416 | 888 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.62 |
2025-09-30 | -$0.79 |
2025-06-30 | -$2.07 |
2025-03-31 | -$3.16 |
